SYMETRYX CORPORATION ACQUIRES 20% STOCK IN NEUBASE
URGES BOARD TO CONSIDER A $1 DIVIDEND
TORONTO, Sept. 6, 2023 /PRNewswire/ - Today, Symetryx Corporation ("Symetryx") announced that it has acquired 20% of the issued and outstanding common stock in Neubase Therapeutics Inc. (NASDAQ:NBSE) ("Neubase"). Symetryx is now urging the Board to issue a special $1 per share dividend.
Symetryx has bought these shares on the open market and intends to engage with the management of Neubase to chart the best path forward for shareholders. Neubase, as disclosed in its previous news releases, is currently undergoing a strategic review of the company's operations.
Symetryx notes that for the quarter ended June 30, 2023, Neubase reported approximate cash bala
